50
Participants
Start Date
May 27, 2020
Primary Completion Date
December 1, 2024
Study Completion Date
December 31, 2025
Lenvatinib
Patients will be treated by lenvatinib as recommended by good clinical practice
RECRUITING
Regina Elena National Cancer Institute, Rome
University of Turin, Italy
OTHER
University of Roma La Sapienza
OTHER
University of Siena
OTHER
University of Pisa
OTHER
Istituto Oncologico Veneto IRCCS
OTHER
University of Catania
OTHER
Istituto Auxologico Italiano
OTHER
Regina Elena Cancer Institute
OTHER